2024-05-23 16:57:09 ET
Evogene Ltd. (EVGN)
Q1 2024 Earnings Conference Call
May 23, 2024 09:00 AM ET
Company Participants
Ofer Haviv - President and Chief Executive Officer
Yaron Eldad - Chief Financial Officer
Yoash Zohar - CEO of Casterra
Dan Jacob Gelvan - CEO of AgPlenus Ltd
Presentation
Operator
Welcome to Evogene's First Quarter Results Conference Call. All participants are present in listen-only mode. Following managements’ formal presentation we will open the call for the question-and-answer session. [Operator Instructions] As a reminder, this conference is being recorded May 23, 2024.
Before we begin, I would like to caution that certain statements made during this earnings conference call by Evogene's Management will constitute forward-looking statements that relate to future events. The presentation contains forward-looking statements relating to future events and Evogene Ltd, the company may from time to time make other statements regarding our outlook or expectations for future financial or operating results and/or other matters regarding or affecting us that are considered forward-looking statements as defined in the US Private Securities Litigation Reform Act of 1995 and other securities laws, as amended.
Statements that are not statements of historical fact may be deemed to be forward-looking statements. Such forward-looking statements may be identified by the use of such words as believe, expect, anticipate, should, plan, estimated, intend and potential or words of similar meaning. We are using forward-looking statements in this presentation when we discuss our value drivers, commercialization, efforts and timing, product development and launches. Estimated market size and milestones pipeline, as well as our capabilities and technology.
Such statements are based on current expectations, estimates, projections and assumptions describe opinions about future events, involve certain risks and uncertainties, which are difficult to predict and are not guarantees of future performance. Readers are cautioned that certain important factors may affect the company's actual results and could cause such results to differ materially from any forward-looking statements that may be made in this presentation. Therefore, actual future results, performance or achievements and trends in the future may differ materially from what is expressed or implied by such forward-looking statements due to a variety of factors, many of which are beyond our control, including without limitation, the current war between Israel Hamas and Hezbollah and any worsening of the situation in Israel such as further mobilizations or escalation in the northern border of Israel and those described in greater detail in Evogene's Annual Report on Form 20-F and in other information Evogene files and furnishes with the Israel Securities Authority, and the US Securities and Exchange Commission, including those factors under the heading Risk Factors....
Read the full article on Seeking Alpha
For further details see:
Evogene Ltd. (EVGN) Q1 2024 Earnings Call Transcript